Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms.

Low, J E

Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms. [electronic resource] - Journal of cardiovascular pharmacology Jun 1995 - 930-9 p. digital

Publication Type: Comparative Study; Journal Article

0160-2446

10.1097/00005344-199506000-00011 doi


Administration, Oral
Adrenergic alpha-Antagonists--administration & dosage
Adrenergic beta-Antagonists--administration & dosage
Animals
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Blood Pressure--drug effects
Cardiomegaly--chemically induced
Catecholamines--blood
Cells, Cultured
Creatine Kinase--metabolism
Disease Models, Animal
Glycogen--metabolism
Heart--drug effects
Heart Rate--drug effects
Infusion Pumps, Implantable
Infusions, Intravenous
L-Lactate Dehydrogenase--metabolism
Microscopy, Electron
Myocardium--cytology
Rats
Rats, Sprague-Dawley
Rats, Wistar
Tetrazoles--administration & dosage
Thiophenes--administration & dosage